Joseph M. Palumbo MD - 05 Jan 2026 Form 4 Insider Report for BIOVIE INC. (BIVI)

Reporting relationship: Chief Medical Officer
Issuer ticker: BIVI
Reported as of: 05 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jan 2026, 17:03:29 UTC
Prior SEC filing: 07 Jan 2025
Next SEC filing: 28 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Joanne Wendy Kim, attorney-in-fact for Joseph M Palumbo, MD

Key filing fact

Joseph M. Palumbo MD filed Form 4 for BIOVIE INC. (BIVI) on 09 Jan 2026.

Key facts

This page summarizes Joseph M. Palumbo MD's Form 4 filing for BIOVIE INC. (BIVI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Jan 2026, 17:03.

Change

Previous filing in this sequence was filed on 07 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001892610 Primary reporting owner

Palumbo Joseph M

Relationship: Chief Medical Officer
Address: C/O BIOVIE INC., 680 W NYE LANE STE 201, CARSON CITY
Signature: /s/ Joanne Wendy Kim, attorney-in-fact for Joseph M Palumbo, MD
Signature date: 09 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIVI transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +132,000
Change %
Price: $0.000000
Shares after: 132,000
Date: 05 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 132,000
Exercise price: $1.31
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

55% of the options vested on January 5, 2026 and the remainder of the options vest in three equal installments on January 5, 2027, January 5, 2028 and January 5, 2029